Orbit SDS
Claire Harris is a highly accomplished academic and industry professional with extensive experience in molecular immunology and drug discovery. Currently serving as Vice President at NewCo and a Board Member of the European Complement Network, Claire also holds an Honorary Professorship at Cardiff University and a Visiting Professorship at Newcastle University. As a principal investigator, Claire leads the Complement Therapeutics Research Group and directs the Complement Diagnostics at the National Renal Complement Therapeutics Centre. Previous roles include Executive Director at Novartis Institutes for BioMedical Research and VP Head of Biology at Gyroscope Therapeutics, focusing on innovative gene therapies for age-related macular degeneration. Claire's academic journey includes significant positions at Cardiff University and GlaxoSmithKline, following the attainment of a PhD in Immunology from the University of Cambridge.
This person is not in any teams
This person is not in any offices
Orbit SDS
The Orbit SDS uses a flexible cannula designed to contour to the globe and access the back of the eye, targeting a subretinal location in ...